Eriko Yasuda

Eriko Yasuda

Auto-generated profile, based on publicly available information

Eriko Yasuda

Nemours/Alfred I duPont Hospital for Children, Wilmington, DE 19803, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2014 in Metabolites
Verified
Journal Article
Open access
PDF file
Shunji TomatsuShunji Tomatsu
Shunji Tomatsu
TSTsutomu Shimada
Tsutomu Shimada
RMRobert W. Mason
Robert W. Mason
AMAdriana M. Montaño
Adriana M. Montaño
JKJoan Kelly
Joan Kelly
TOTadao Orii
Tadao Orii
Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by deficiency of the lysosomal enzymes essential for catabolism of glycosaminoglycans (GAGs). Accumulation of undegraded GAGs results in dysfunction of multiple organs, resulting in distinct clinical manifestations. A range of methods have been developed to measure specific GAGs in various human samples to investigate diagnosis, prognosis, pathogenesis, GAG interaction with other molecules, and monitoring therapeutic efficacy. We established ELISA, liquid chromatography tandem mass spectrometry (LC-MS/MS), and an automated high-throughput mass spectrometry (HT-MS/MS) system (RapidFire) to identify epitopes (ELISA) or disaccharides (MS/MS) derived from different GAGs (dermatan sulfate, heparan sulfate, keratan sulfate, and/or chondroitin sulfate). These methods have a high sensitivity and specificity in GAG analysis, applicable to the analysis of blood, urine, tissues, and cells. ELISA is feasible, sensitive, and reproducible with the standard equipment. HT-MS/MS yields higher throughput than conventional LC-MS/MS-based methods while the HT-MS/MS system does not have a chromatographic step and cannot distinguish GAGs with identical molecular weights, leading to a limitation of measurements for some specific GAGs. Here we review the advantages and disadvantages of these methods for measuring GAG levels in biological specimens. We also describe an unexpected secondary elevation of keratan sulfate in patients with MPS that is an indirect consequence of disruption of catabolism of other GAGs.

1 February 2015 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
Francyne KubaskiFrancyne Kubaski
Francyne Kubaski
TSTsutomu Shimada
Tsutomu Shimada
STShunji Tomatsu
Shunji Tomatsu
RMRobert W. Mason
Robert W. Mason
EYEriko Yasuda
Eriko Yasuda
TOTadao Orii
Tadao Orii

1 February 2013 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
STShunji Tomatsu
Shunji Tomatsu
YSYasuyuki Suzuki
Yasuyuki Suzuki
TOTadao Orii
Tadao Orii
EYEriko Yasuda
Eriko Yasuda
KRKristen Ruhnke
Kristen Ruhnke
WMWilliam Mackenzie
William Mackenzie

1 February 2015 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
STShunji Tomatsu
Shunji Tomatsu
TSTsutomu Shimada
Tsutomu Shimada
WLWilliam A. LaMarr
William A. LaMarr
NVNaomi V. Vlies
Naomi V. Vlies
EYEriko Yasuda
Eriko Yasuda
TOTadao Orii
Tadao Orii

1 February 2015 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
Francyne KubaskiFrancyne Kubaski
Francyne Kubaski
STShunji Tomatsu
Shunji Tomatsu
PPPravin Patel
Pravin Patel
TSTsutomu Shimada
Tsutomu Shimada
SXSherlly L. Xie
Sherlly L. Xie
TSThomas Shaffer
Thomas Shaffer

1 February 2015 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
STShunji Tomatsu
Shunji Tomatsu
JTJulian Tanjuakio
Julian Tanjuakio
YSYasuyuki Suzuki
Yasuyuki Suzuki
PPPravin Patel
Pravin Patel
EYEriko Yasuda
Eriko Yasuda
TOTadao Orii
Tadao Orii